We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
+29.65%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.58B
AUM Growth
+$264M
Cap. Flow
-$56.9M
Cap. Flow %
-3.61%
Top 10 Hldgs %
70.28%
Holding
330
New
38
Increased
107
Reduced
155
Closed
24

Top Sells

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$23.4M
2
YUMC icon
Yum China
YUMC
+$14M
3
TSM icon
TSMC
TSM
+$8.84M
4
PDD icon
Pinduoduo
PDD
+$8.79M
5
AAPL icon
Apple
AAPL
+$4.77M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 50.26%
2 Technology 23.48%
3 Communication Services 8.85%
4 Real Estate 5.2%
5 Healthcare 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REPL icon
276
Replimune Group
REPL
$1.49B
$209K 0.01%
+24,739
New +$287K
MIRM icon
277
Mirum Pharmaceuticals
MIRM
$5.95B
$207K 0.01%
7,001
-49
-0.7% -$1.48K
TVTX icon
278
Travere Therapeutics
TVTX
$6.24B
$206K 0.01%
22,910
+4,314
+23% +$31.4K
PTGX icon
279
Protagonist Therapeutics
PTGX
$9.26B
$205K 0.01%
8,957
-9,034
-50% -$158K
CAT icon
280
Caterpillar
CAT
$369B
$204K 0.01%
690
-107
-13% -$27.8K
MTD icon
281
Mettler-Toledo International
MTD
$28B
$203K 0.01%
+167
New +$181K
VCEL icon
282
Vericel Corp
VCEL
$2.11B
$202K 0.01%
5,683
-750
-12% -$26.1K
UNP icon
283
Union Pacific
UNP
$183B
$202K 0.01%
+823
New +$181K
CNC icon
284
Centene
CNC
$32B
$200K 0.01%
+2,700
New +$195K
BA icon
285
Boeing
BA
$165B
$200K 0.01%
+768
New +$164K
IBRX icon
286
ImmunityBio
IBRX
$8.48B
$198K 0.01%
+39,494
New +$124K
EDIT icon
287
Editas Medicine
EDIT
$511M
$194K 0.01%
19,134
-6,321
-25% -$55.5K
RLAY icon
288
Relay Therapeutics
RLAY
$4.12B
$193K 0.01%
17,486
-1,917
-10% -$16.2K
GERN icon
289
Geron
GERN
$970M
$189K 0.01%
89,633
-8,075
-8% -$15.7K
HPE icon
290
Hewlett Packard
HPE
$69.4B
$185K 0.01%
10,915
-811
-7% -$13.2K
DAWN
291
DELISTED
Day One Biopharmaceuticals
DAWN
$184K 0.01%
12,618
+442
+4% +$5.36K
SIRI icon
292
SiriusXM
SIRI
$9.58B
$181K 0.01%
3,304
-321
-9% -$15.4K
VTRS icon
293
Viatris
VTRS
$18.9B
$179K 0.01%
16,562
+5,921
+56% +$56.7K
MNKD icon
294
MannKind Corp
MNKD
$1.27B
$159K 0.01%
43,621
-334
-0.8% -$1.28K
QURE icon
295
uniQure
QURE
$3.43B
$133K 0.01%
19,687
-388
-2% -$2.56K
CDMO
296
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$132K 0.01%
+20,349
New +$131K
ADMA icon
297
ADMA Biologics
ADMA
$2.1B
$131K 0.01%
29,060
-3,069
-10% -$11.4K
CDNA icon
298
CareDx
CDNA
$2.61B
$122K 0.01%
10,165
-5,518
-35% -$45.2K
CRBU icon
299
Caribou Biosciences
CRBU
$173M
$117K 0.01%
20,351
-5,714
-22% -$28.2K
AVXL icon
300
Anavex Life Sciences
AVXL
$276M
$115K 0.01%
12,388
-1,520
-11% -$10.5K

Similar funds

E Fund Management's Q4 2023 Portfolio in Review

As of Q4 2023, E Fund Management held 330 positions worth $1.58B, up 20% from $1.31B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

E Fund Management withdrew a net $56.9M in Q4 2023, closing 24 positions and reducing 155 holdings. Its most notable exit was MINISO, an estimated $2.17M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 45% a quarter earlier, followed by Technology and Communication Services.

Against the trend, E Fund Management opened a new position in Hesai Group worth $1.52M.

  • E Fund Management's largest Q4 2023 buy was Hesai Group: 170,914 shares worth $1.52M.
  • E Fund Management added most to JOYY Inc in Q4 2023, an estimated $3.5M increase.
  • E Fund Management's biggest Q4 2023 reduction was STAAR Surgical, cutting an estimated $23.4M.
  • E Fund Management fully exited MINISO in Q4 2023, selling an estimated $2.17M.
  • E Fund Management's ten largest holdings make up 70% of its $1.58B portfolio in Q4 2023.
  • E Fund Management opened 38 new positions and closed 24 in Q4 2023.
  • E Fund Management's portfolio value rose 20% quarter-over-quarter to $1.58B.

Based on E Fund Management's 13F filing for Q4 2023, filed 7 Feb 2024.